Revenue
No reported data
Jyong Biotech Ltd. (MENS)
Price—Loading quote
Net income
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Research & development | $813,000 | $927,000 | $1.1M |
| Operating expenses | $2.6M | $2.1M | $2.8M |
| Operating income | −$2.6M | −$2.1M | −$2.8M |
| EBITDAderived | −$2.5M | −$1.9M | −$2.7M |
| Net income | −$4.7M | −$3.0M | −$4.4M |
| Basic EPSper diluted share | -$0.06 | -$0.04 | -$0.06 |
| Diluted EPSper diluted share | -$0.06 | -$0.04 | -$0.06 |